Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Open-Label, 24 Week Regimen of 8 mg Pegloticase i.v. in Symptomatic Gout Subjects Who Participated in Previous Studies of Pegloticase i.v.

NCT00675103 is registered in ClinicalTrials.gov with Savient Pharmaceuticals as lead sponsor.

NCT NCT00675103
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00675103 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Open-Label, 24 Week Regimen of 8 mg Pegloticase i.v. in Symptomatic Gout Subjects Who Participated in Previous Studies of Pegloticase i.v.
Lead sponsor
Savient Pharmaceuticals
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2008
Completion date
April 30, 2009
Enrollment
7 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

chronic gout refractory to conventional therapy